DexCom (DXCM) G4 Demand 'Durable' - Jefferies
Jefferies analyst Raj Denhoy boosted his price target on DexCom (NASDAQ: DXCM) from $21 to $27 following a strong Q2 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
